168 related articles for article (PubMed ID: 38464986)
1. Mortality After Alcohol Septal Ablation vs. Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy.
Yasuda R; Osawa I; Goto T; Hasegawa K; Fifer MA; Tower-Rader A; Reilly MP; Maurer MS; Zhao Y; Takayama H; Shimada YJ
Circ Rep; 2024 Mar; 6(3):74-79. PubMed ID: 38464986
[No Abstract] [Full Text] [Related]
2. Effects of Septal Reduction Therapy on Acute Cardiovascular Events and All-Cause Mortality in Patients with Hypertrophic Cardiomyopathy.
Morita SX; Zhao Y; Hasegawa K; Fifer MA; Maurer MS; Reilly MP; Takayama H; Shimada YJ
Int Heart J; 2021 Sep; 62(5):1035-1041. PubMed ID: 34544977
[TBL] [Abstract][Full Text] [Related]
3. Survival After Septal Reduction in Patients >65 Years Old With Obstructive Hypertrophic Cardiomyopathy.
Mentias A; Smedira NG; Krishnaswamy A; Reed GW; Ospina S; Thamilarasan M; Popovic ZB; Xu B; Kapadia SR; Desai MY
J Am Coll Cardiol; 2023 Jan; 81(2):105-115. PubMed ID: 36631204
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Surgical Ventricular Septal Reduction to Alcohol Septal Ablation Therapy in Patients with Hypertrophic Cardiomyopathy.
Bourque C; Réant P; Bernard A; Leroux L; Bonnet G; Pernot M; Bisson A; Herbert J; Saint-Etienne C; Lafitte S; Fauchier L
Am J Cardiol; 2022 Jun; 172():109-114. PubMed ID: 35351287
[TBL] [Abstract][Full Text] [Related]
5. Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy.
Cui H; Schaff HV; Wang S; Lahr BD; Rowin EJ; Rastegar H; Hu S; Eleid MF; Dearani JA; Kimmelstiel C; Maron BJ; Nishimura RA; Ommen SR; Maron MS
J Am Coll Cardiol; 2022 May; 79(17):1647-1655. PubMed ID: 35483751
[TBL] [Abstract][Full Text] [Related]
6. Hospital Volume Outcomes After Septal Myectomy and Alcohol Septal Ablation for Treatment of Obstructive Hypertrophic Cardiomyopathy: US Nationwide Inpatient Database, 2003-2011.
Kim LK; Swaminathan RV; Looser P; Minutello RM; Wong SC; Bergman G; Naidu SS; Gade CL; Charitakis K; Singh HS; Feldman DN
JAMA Cardiol; 2016 Jun; 1(3):324-32. PubMed ID: 27438114
[TBL] [Abstract][Full Text] [Related]
7. Costs and Healthcare Resource Utilization for Obstructive Hypertrophic Cardiomyopathy With Septal Reduction Therapy.
Butzner M; Maron MS; Sarocco P; Teng CC; Stanek E; Tan H; Robertson LA
J Invasive Cardiol; 2022 Dec; 34(12):E866-E872. PubMed ID: 36288089
[TBL] [Abstract][Full Text] [Related]
8. Septal Myectomy or Alcohol Ablation for Hypertrophic Cardiomyopathy: A Nationwide Inpatient Sample (NIS) Database Analysis.
Ullah W; Warner E; Khandait H; Sachdeva S; Abdalla AS; Shafique M; Khan MA; Roomi S; Khattak F; Alraies MC
Cardiovasc Revasc Med; 2023 May; 50():54-58. PubMed ID: 36737383
[TBL] [Abstract][Full Text] [Related]
9. Alcohol septal ablation vs myectomy for symptomatic hypertrophic obstructive cardiomyopathy: Systematic review and meta-analysis.
Osman M; Kheiri B; Osman K; Barbarawi M; Alhamoud H; Alqahtani F; Alkhouli M
Clin Cardiol; 2019 Jan; 42(1):190-197. PubMed ID: 30421437
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy.
Sedehi D; Finocchiaro G; Tibayan Y; Chi J; Pavlovic A; Kim YM; Tibayan FA; Reitz BA; Robbins RC; Woo J; Ha R; Lee DP; Ashley EA
J Cardiol; 2015 Jul; 66(1):57-62. PubMed ID: 25238885
[TBL] [Abstract][Full Text] [Related]
11. A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic Cardiomyopathy.
Liebregts M; Vriesendorp PA; Mahmoodi BK; Schinkel AF; Michels M; ten Berg JM
JACC Heart Fail; 2015 Nov; 3(11):896-905. PubMed ID: 26454847
[TBL] [Abstract][Full Text] [Related]
12. Alcohol Septal Ablation or Septal Myectomy? An Updated Systematic Review and Meta-Analysis of Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy.
Zheng X; Yang B; Hui H; Lu B; Feng Y
Front Cardiovasc Med; 2022; 9():900469. PubMed ID: 35694661
[TBL] [Abstract][Full Text] [Related]
13. Gender-Based Outcome Discrepancies in Patients Who Underwent Alcohol Septal Ablation or Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy: A Systematic Review and Meta-Analysis.
Saravanabavanandan R; Jaimalani A; Khan MAN; Riaz S; Mangas GM; Ahsan SM; Posani S; Patel T; Fawad M; Al-Tawil M
Am J Cardiol; 2023 Dec; 208():134-142. PubMed ID: 37839170
[TBL] [Abstract][Full Text] [Related]
14. Predictors of long-term outcome after septal myectomy in symptomatic hypertrophic obstructive cardiomyopathy patients with previous alcohol septal ablation and residual obstruction.
Zhu C; Tang B; Cui H; Wang S; Xiao M; Chen Z; Meng Y; Zhao S; Song Y; Yu Q; Wang S
J Card Surg; 2019 Jul; 34(7):533-540. PubMed ID: 31111576
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal Cost of Septal Myectomy Versus Alcohol Septal Ablation for Hypertrophic Cardiomyopathy.
Sun D; Schaff HV; Van Houten HK; Nguyen A; Sangaralingham LR; Nishimura RA; Geske JB; Dearani JA; Ommen SR
Mayo Clin Proc; 2022 Sep; 97(9):1656-1663. PubMed ID: 36058579
[TBL] [Abstract][Full Text] [Related]
16. Differences in Short-Term Outcomes and Hospital-Based Resource Utilization Between Septal Reduction Strategies for Hypertrophic Obstructive Cardiomyopathy.
Yandrapalli S; Harikrishnan P; Andries G; Aronow WS; Panza JA; Naidu SS
J Invasive Cardiol; 2022 Jan; 34(1):E8-E13. PubMed ID: 34919530
[TBL] [Abstract][Full Text] [Related]
17. Surgical septal myectomy or alcohol septal ablation: which approach offers better outcomes for patients with hypertrophic obstructive cardiomyopathy?
Poon SS; Field M; Gupta D; Cameron D
Interact Cardiovasc Thorac Surg; 2017 Jun; 24(6):951-961. PubMed ID: 28329292
[TBL] [Abstract][Full Text] [Related]
18. Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience.
Steggerda RC; Damman K; Balt JC; Liebregts M; ten Berg JM; van den Berg MP
JACC Cardiovasc Interv; 2014 Nov; 7(11):1227-34. PubMed ID: 25326737
[TBL] [Abstract][Full Text] [Related]
19. Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation.
Yang Q; Zhu C; Cui H; Tang B; Wang S; Yu Q; Zhao S; Song Y; Wang S
J Thorac Dis; 2021 Feb; 13(2):1055-1065. PubMed ID: 33717578
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Effectiveness of Alcohol Septal Ablation Versus Ventricular Septal Myectomy on Acute Care Use for Cardiovascular Disease in Patients With Hypertrophic Cardiomyopathy.
Shimada YJ; Goto T; Takayama H; Brown DFM; Homma S; Maurer MS; Reilly MP; Hasegawa K
Am J Cardiol; 2019 Oct; 124(8):1272-1278. PubMed ID: 31447010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
